USPTO Patents Application 09993647

EFSID:

7718336

Application Number:

09993647

International Application Number:

Confirmation Number:

1010

Title of Invention:

omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

First Named Inventor/Applicant Name:

Bernd Riedl

Customer Number:

23599

Filer:

Csaba Henter/Caitlin Sickler

Filer Authorized By:

Csaba Henter

Attorney Docket Number:

BAYER ISA

Receipt Date:

Ol-JUN-2010

Filing Date:

27-NOV-2001

Time Stamp:

13:49:09

Application Type:

Utility under 35 USC 111(a)

Payment information:

Submitted with Payment

no

File Listing:

Document
Number

Document Description

File Name

FileSize(Bytes)/
Message Digest

Multi
Part /.zip

Pages
(if appl.)

1

NPL Documents

P61-

DEVLINETALGattandDiscovery.
pdf

237243

7c95cd9040bd55355c2f8b5f06e2ddcd621
5dl5f

no

3

Warnings:

Information:

2

NPL Documents

P62DOANESETALVEG.pdf

303285

no

4

76a7aOf9bbbd4aa7751 3bbafae1 9c491 03c
4cfcb

Warnings:

Information:

3

NPL Documents

P63-

DORWALDSideReactionsOrgani
cSynthesis.pdf

425786

no

3

bdcd653dd3f21e3d037303a50e24ef5b5fb
IfSIO

Warnings:

Information:

4

NPL Documents

P64-

DOWNWARDMECHANISMSAN
DCONSEQUENCESOFACTIVATI
ONOFPROTEINKINASE.pdf

599463

no

6

6c7facceebf0cf2c48b46afOf59a048dc8e57
564

Warnings:

Information:

5

NPL Documents

P64a-Drevs-et-al-Ann-Oncol-
Vl6-n4-p558.pdf

1345043

no

8

b816d98d48e7387c4d57dfa612df7299490
64234

Warnings:

Information:

6

NPL Documents

P64b-

DrevsJAnticancerResv23pl 1 59.
pdf

278857

no

4

97dace013ff142bbf2192d396ebe7eb7bba
ebddO

Warnings:

Information:

7

NPL Documents

P64c-

DrevsDieMedizinischeWelt.PDF

352668

no

3

d3e932ac620a201a7d727205089fbdf7062
88605

Warnings:

Information:

8

NPL Documents

P65-

DrugFactsandComparisonsl 99
4edition.pdf

662046

no

4

7becd3b04c38301d229988d589cc253a62f
e132e

Warnings:

Information:

9

NPL Documents

P65a-Dudek-and-Mahaseth-
Cancer-lnvest-v23-pl 93.pdf

528035

no

8

247d0acf8bfe1a1431122e3f0789ae59dcdc
73a

Warnings:

Information:

10

NPL Documents

P66-

DumasProtienKinaselnhibitorsf
ormtheUreaClass.pdf

750454

no

10

2832fb0f9b242eda77836f4466046fb88d49
bb03

Warnings:

Information:

11

NPL Documents

P67Dumas2000.pdf

155092

no

4

65503af91fe34f1770aa80bce8fd24554e98
7a7e

Warnings:

Information:

12

NPL Documents

P68a-

DumasJGrowthFactorReceptor
Kinase.pdf

1180537

no

12

5ab3c8d78ca3ff17e71d451932b8882e8d5
dbSbb

Warnings:

Information:

13

NPL Documents

P68-Dumasl-Phenyl-5-
pyrazolylUreasPotentandSelect
ivep38Kinaselnhibitors.pdf

281356

no

4

b405c6dc9d8fca3a99fe9ed8fc2d0a307762
6ef7

Warnings:

Information:

14

NPL Documents

P68b-

DumasJProteinKinaselnhibitors
.pdf

1745212

no

25

336fe85d2801 d1 1 dff2b37eab00aead41fb0
4774

Warnings:

Information:

15

NPL Documents

P68c-

DumasetalOralActivep38Kinase
lnhibitorsMEDI256-l.pdf

92343

no

1

97b070d350767dba486223c25e2aed04e81
6a210

Warnings:

The page size in the PDF is too large. The pages should be 8.5 x 1 1 or A4. If this PDF is submitted, the pages will be resized upon entry into the
Image File Wrapper and may affect subsequent processing

Information:

16

NPL Documents

P68d-

DumasJRafKinaselnhibitors.pdf

230963

no

2

0b3a99998e8e47c9c7c8c40071de96d08a5
6aea6

Warnings:

Information:

17

NPL Documents

P69-

DumasRecentDevelopmentsin
DiscoveryofProteinKinaselnhibi
torsfromtheUreaClass.pdf

1279668

no

17

8b39b27fa2be83f26cfbf1f619185835d3a8
7a33

Warnings:

Information:

18

NPL Documents

P70-DUMASETAL-
SynthesisOrallyActivep38.pdf

367020

no

4

e90c2ec8b7d97c4c012703ed321c73565ae
2ff89

Warnings:

Information:

19

NPL Documents

P70a-Dunst-et-al-Strahlenther-
Onkol-vl77-p469.pdf

118016

no

5

a3479c41 1 ebdbd83db725c5ed320d1 3f3dc
4f4da

Warnings:
Information:

20

NPL Documents

P71-EBOS-MultipleCirculation.
pdf

396525

a2fc5eee7fc02873c7eccf4823309289316d2
af7

Warnings:

Information:

Total Files Size (in bytes)

11329612

This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
Post Card, as described in MPEP 503.

New Applications Under 35 U.S.C. 1 1 1

If a new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
1 .53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1 .54) will be issued in due course and the date shown on this
Acknowledgement Receipt will establish the filing date of the application.

National Stage of an International Application under 35 U.S.C. 371

If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.

New International Application Filed with the USPTO as a Receiving Office

If a new international application is being filed and the international application includes the necessary components for
an international filing date (see PCT Article 1 1 and MPEP 1 81 0), a Notification of the International Application Number
and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
the application.